| A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome (NCT00002127) | Celgene Corporation | |
| A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma (NCT00002131) | Otsuka America Pharmaceutical | |
| A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00002367) | Hoffmann-La Roche | |
| A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3 (NCT00000844) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men (NCT00063804) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance (NCT00046033) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients (NCT00001085) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma (NCT00002366) | Abbott | |
| The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients (NCT00061256) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3) (NCT00000649) | Boehringer Ingelheim | |
| Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia (NCT00002148) | University of Rochester | |
| The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy (NCT00000850) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China (NCT00068991) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease (NCT00000719) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients (NCT00002211) | Pharmacia and Upjohn | |
| Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors (NCT00002193) | Glaxo Wellcome | |
| A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients (NCT00002248) | Univax Biologics Inc | |
| Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda (NCT01549470) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults (NCT01964937) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection (NCT00038272) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples (NCT00000928) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3 (NCT00000771) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. (NCT00002138) | Daiichi Pharmaceuticals | |
| A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts (NCT00000908) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study (NCT00002082) | Pfizer | |
| Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs (NCT00050063) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection (NCT00002347) | Parexel | |
| The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs (NCT00002368) | Boehringer Ingelheim | |
| Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection (NCT00000959) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea (NCT00002264) | Stolle Milk Biologic International | |
| Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy (NCT00002109) | Immunobiology Research Institute | |
| A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT (NCT00001032) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia (NCT00002317) | U.S. Bioscience | |
| A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia (NCT00002154) | The Dana Foundation | |
| The Effects of Zidovudine on the Blood of HIV-Infected Patients (NCT00000965) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00002292) | LyphoMed | |
| A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS (NCT00002278) | Janssen, LP | |
| Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus (NCT00006643) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis (NCT00000950) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients (NCT00002396) | Gilead Sciences | |
| A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women (NCT00000839) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only) (NCT00000958) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities (NCT00015691) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients (NCT00001023) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women (NCT00000862) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic (NCT00002303) | Ortho Pharmaceuticals | |
| A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease (NCT00000805) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of HIV in Newly Infected Individuals (NCT00000930) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS) (NCT00002186) | Shaman Pharmaceuticals | |
| A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects (NCT00002353) | United Biomedical | |
| Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome (NCT00002112) | Pfizer | |
| Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms (NCT00000707) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment (NCT00001069) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluation of the Interaction Between Acetaminophen and Zidovudine (NCT00000731) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients (NCT00002099) | AJI Pharma USA | |
| Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers (NCT00039975) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B (NCT00007332) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS (NCT00002433) | Amgen | |
| Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials (NCT00183287) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection (NCT00017784) | Hoffmann-La Roche | |
| A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis. (NCT00002113) | Pfizer | |
| A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002 (NCT00000682) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega (NCT00002359) | The Immune Response Corporation | |
| A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection (NCT00006154) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery (NCT00540605) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy (NCT00000722) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. (NCT00002167) | Clinical Solutions | |
| The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs (NCT00001087) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults (NCT00002204) | Chiron Corporation | |
| A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment (NCT00006152) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon (NCT00215891) | Hepatitis Resource Network | |
| Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome (NCT00000627) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants (NCT00000829) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine in HIV-Infected Patients With Liver Disease (NCT00001001) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors (NCT00004580) | Abbott | |
| A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy (NCT00002061) | Newport Pharmaceuticals International | |
| A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS (NCT00002116) | Gilead Sciences | |
| Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers (NCT00000690) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients (NCT00001022) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients (NCT00000912) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment (NCT00002419) | Gilead Sciences | |
| A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir) (NCT00002028) | Bristol-Myers Squibb | |
| The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection (NCT00002298) | ICN Pharmaceuticals | |
| Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs (NCT00004855) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns (NCT00006396) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination (NCT00002416) | Triangle Pharmaceuticals | |
| A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients (NCT00002382) | Hoffmann-La Roche | |
| Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3. (NCT00000818) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru (NCT00023582) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023) (NCT00377065) | Merck Sharp & Dohme LLC | |
| 3TC (Lamivudine; GR109714X) Open-Label Program (NCT00002108) | Glaxo Wellcome | |
| Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis (NCT00023218) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV Infection (NCT00002290) | Glaxo Wellcome | |
| A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection (NCT00000760) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients (NCT00001057) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children (NCT00002219) | Gilead Sciences | |
| A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults (NCT00001052) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System (NCT00002288) | Glaxo Wellcome | |
| A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3 (NCT00001064) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV) (NCT00431548) | Medical University of Vienna | |